The anniversary commemoration event took place on Wednesday 29 June at the Esteve Auditorium of the Esther Koplowitz Centre. The event could also be1
Researchers from Hospital Clínic-IDIBAPS are leading a study that provides new evidence regarding the benefits and risks of corticosteroid treatment,1
During the “PKU”liar day, held on 28 June, the latest advances in the disease were presented and workshops were organised aimed at patients and famil1
A weekly dose for a year and a half has been shown to reduce weight by 21% in obese people
The administration of the antibody mavrilimumab in conjunction with prednisone reduces the risk of exacerbation of symptoms of the disease and improv1
Researchers from the Hospital Clínic-IDIBAPS and the CIBERSAM participate in a study that evidences the involvement of numerous genes in the developm1
Studies have shown that this drug improves sleep and daytime performance in people with insomnia, without causing a sedative effect the next day, as1
Researchers from the Hospital Clínic-IDIBAPS are leading a study to obtain information on 10,000 healthy people who do not have Parkinson's disease,1
This award, worth 35,000 euros, recognises the researcher’s contribution to clinical research in diet and nutrition.
The deadline for applications is the 28th August and 2 of the 15 fellows will be hired by IDIBAPS.